← Back to Patent Explorer
US4000161A Expired / Lapsed US ⏱️ 0.0 years remaining

Process for purifying thienamycin

Assignee: Merck and Co Inc
•
Filing: 1975-09-18
•
Granted: 1976-12-28
•
Expires: 1995-09-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Fermentation broths or impure solutions containing thienamycin, a substance having antibiotic activity against gram-negative and gram-positive microorganisms, are purified using ion exchange resins, poly-acrylamide gels or adsorbents such as polyester polymers or polystyrene, hydrophobic crosslinked divinyl benzene polymers.

Inventors

  • 👤 Robert T. Goegelman
  • 👤 Frederick M. Kahan

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-04 11:02
CPC Classifications
C; C12; C12P; C12P17/00; C12P17/18; C12P17/182; C12P17/184; A; A61; A61P; A61P31/00; A61P31/04; C07; C07D; C07D477/00; C07D477/02

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 105 words
A process for recovering the antibiotic thienamycin from fermentation broths or from solutions containing said antibiotic which comprises passing a fermentation broth or a solution containing said antibiotic through a column packed with a cation exchange resin containing sulfonic acid exchange groups; eluting the resin adsorbate with a base; collecting the eluates; combining the active fractions; and passing said combined fractions through a column packed with polyacrylamide or dextran gel which excludes molecules having a molecular weight greater than 1,800 and 700 respectively; eluting the gel with water or with an aqueous solution of a lower alcohol; collecting the eluates and combining the active fractions.
Claim 2
Dependent Claim 105 words
A process for recovering the antibiotic thienamycin from fermentation broths or from solutions containing said antibiotic which comprises passing a fermentation broth or a solution containing said antibiotic through a column packed with a cation exchange resin containing sulfonic acid exchange groups; eluting the resin adsorbate with a base; collecting the eluates; combining the active fractions; and passing said combined fractions through a column packed with polyacrylamide or dextran gel which excludes molecules having a molecular weight greater than 1,800 and 700 respectively; eluting the gel with water or with an aqueous solution of a lower alcohol; collecting the eluates and combining the active fractions.
Claim 3
Dependent Claim 130 words
A process for recovering the antibiotic thienamycin from fermentation broths or from solutions containing said antibiotic which comprises passing a fermentation broth or a solution containing said antibiotic through a column packed with a cation exchange resin containing sulfonic acid exchange groups; eluting the resin adsorbate with a base; collecting the eluates; combining the active fractions; percolating said active fractions eluted from the cation exchange resin through a column packed with an anion exchange resin of the polystryrene-quaternary ammonium type; collecting the effluent; passing the effluent through a column packed with polyacrylamide or dextran gel which excludes molecules having a molecular weight greater than 1,800 and 700 respectively; eluting the gel with water or with an aqueous solution of a lower alcohol; collecting the eluates and combining the active fractions.
Claim 4
Dependent Claim 130 words
A process for recovering the antibiotic thienamycin from fermentation broths or from solutions containing said antibiotic which comprises passing a fermentation broth or a solution containing said antibiotic through a column packed with a cation exchange resin containing sulfonic acid exchange groups; eluting the resin adsorbate with a base; collecting the eluates; combining the active fractions; percolating said active fractions eluted from the cation exchange resin through a column packed with an anion exchange resin of the polystryrene-quaternary ammonium type; collecting the effluent; passing the effluent through a column packed with polyacrylamide or dextran gel which excludes molecules having a molecular weight greater than 1,800 and 700 respectively; eluting the gel with water or with an aqueous solution of a lower alcohol; collecting the eluates and combining the active fractions.
Claim 5
Dependent Claim 191 words
A process for recovering the antibiotic thienamycin from fermentation broths or from solutions containing said antibiotic which comprises passing a fermentation broth or a solution containing said antibiotic through a column packed with a cation exchange resin containing sulfonic acid exchange groups; eluting the resin adsorbate with a base; collecting the eluates; combining the active fractions; percolating said active fractions eluted from the cation exchange resin throgh a column packed with an anion exchange resin of the polystyrene-quarternary ammonium type; collecting the effluent; passing said effluent through a column packed with a cation exchange resin containing nuclear sulfonic acid exchange groups; eluting the resin adsorbate with a buffer or water; combining the active fractions; passing said active fractions through a column packed with polyacrylamide or dextran gel which exludes molecules having a molecular weight greater than 1,800 and 700 respectively; eluting the gel with water or with an aqueous solution of a lower alcohol; collecting the eluates; combining the active fractions; concentrating said fractions; adsorbing said concentrate on a column packed with a polystyrene, hydrophobic crosslinked divinylbenzene polymer; eluting the polymer with water; collecting the eluate and combining the active fractions.
Claim 6
Dependent Claim 191 words
A process for recovering the antibiotic thienamycin from fermentation broths or from solutions containing said antibiotic which comprises passing a fermentation broth or a solution containing said antibiotic through a column packed with a cation exchange resin containing sulfonic acid exchange groups; eluting the resin adsorbate with a base; collecting the eluates; combining the active fractions; percolating said active fractions eluted from the cation exchange resin throgh a column packed with an anion exchange resin of the polystyrene-quarternary ammonium type; collecting the effluent; passing said effluent through a column packed with a cation exchange resin containing nuclear sulfonic acid exchange groups; eluting the resin adsorbate with a buffer or water; combining the active fractions; passing said active fractions through a column packed with polyacrylamide or dextran gel which exludes molecules having a molecular weight greater than 1,800 and 700 respectively; eluting the gel with water or with an aqueous solution of a lower alcohol; collecting the eluates; combining the active fractions; concentrating said fractions; adsorbing said concentrate on a column packed with a polystyrene, hydrophobic crosslinked divinylbenzene polymer; eluting the polymer with water; collecting the eluate and combining the active fractions.
Claim 7
Dependent Claim 111 words
A process for recovering the antibiotic thienamycin from fermentation broths or from solutions containing said antibiotic which comprises passing a fermentation broth or a solution containing said antibiotic through a column packed with a cation exchange resin containing sulfonic acid exchange groups; eluting the resin adsorbate with a base; collecting the eluates; combining the active fractions; percolating said active fractions eluted from the cation exchange resin through a column packed with an anion exchange resin of the polystyrene-quaternary ammonium type; concentrating the effluent; adsorbing the concentrated effluent on a column packed with a polystyrene, hydrophobic crosslinked divinylbenzene polymer; eluting the polymer with water; collecting the eluate and combining the active fractions.
Claim 8
Dependent Claim 111 words
A process for recovering the antibiotic thienamycin from fermentation broths or from solutions containing said antibiotic which comprises passing a fermentation broth or a solution containing said antibiotic through a column packed with a cation exchange resin containing sulfonic acid exchange groups; eluting the resin adsorbate with a base; collecting the eluates; combining the active fractions; percolating said active fractions eluted from the cation exchange resin through a column packed with an anion exchange resin of the polystyrene-quaternary ammonium type; concentrating the effluent; adsorbing the concentrated effluent on a column packed with a polystyrene, hydrophobic crosslinked divinylbenzene polymer; eluting the polymer with water; collecting the eluate and combining the active fractions.
Claim 9
Dependent Claim 52 words
The process of claim 4 which comprises eluting the polystyrene, hydrophobic crosslinked divinylbenzene polymer with phosphate buffer; collecting the eluate; combining the active fractions; adsorbing the active fractions on a column packed with a polystyrene, hydrophobic crosslinked divinylbenzene polymer; eluting the polymer with water; collecting the eluate and combining the active fractions.
Claim 10
Dependent Claim 42 words
A process for recovering the antibiotic thienamycin free of inorganic ions which comprises adsorbing solutions containing thienamycin and inorganic ions on a column packed with the polystyrene resin, XAD-2; eluting the polymer with water; collecting the eluate and combining the active fractions.
Claim 11
Dependent Claim 42 words
A process for recovering the antibiotic thienamycin free of inorganic ions which comprises adsorbing solutions containing thienamycin and inorganic ions on a column packed with the polystyrene resin, XAD-2; eluting the polymer with water; collecting the eluate and combining the active fractions.
Claim 12
Dependent Claim 48 words
The process according to claim 3 which additionally comprises passing said active fractions eluted from polyacrylamide or dextran gel at least once through a column packed with a poly-styrene, hydrophobic crosslinked divinyl benzene polymer, eluting with phosphate buffer or water; collecting the eluates and combining the active fractions.
Claim 13
Dependent Claim 25 words
The process of claim 1 wherein the cation exchange resin is composed of sulfonic exchange groups in the sodium cycle attached to a styrene-divinylbenzene matrix.
Claim 14
Dependent Claim 25 words
The process of claim 2 wherein the cation exchange resin is composed of sulfonic exchange groups in the sodium cycle attached to a styrene-divinylbenzene matrix.
Claim 15
Dependent Claim 24 words
The process of claim 3 wherein the cation exchange resin is composed of sulfonic groups in the sodium cycle attached to a styrene-divinylbenzene matrix.
Claim 16
Dependent Claim 27 words
The process of claim 2 wherein the anion exchange resin is composed of quaternary ammonium exchange groups in the chloride cycle attached to a styrene-divinylbenzene polymer matrix.
Claim 17
Dependent Claim 14 words
The process of claim 1 wherein the polyacrylamide gel is eluted with n-butanol:water (1:99).
Claim 18
Dependent Claim 52 words
The process of claim 1 wherein the column packed with the cation exchange resin is eluted with an aqueous solution of an organic base wherein the base is selected from the group consisting of pyridine; α,β,γ-picoline; 2,3-;2,4-; and 2,6-lutidine; 2,4,6-collidine and alkylamines wherein the alkyl groups contain 2 to 10 carbon atoms.
Claim 19
Dependent Claim 38 words
The process of claim 3 wherein said buffer is selected from the group consisting of tris(hydroxymethyl)aminomethane maleate, cacodylic acid, KH 2 PO 4 , NaH 2 PO 4 , N-ethylmorpholine, α-, β- or γ-picoline and 2,3-;2,4-; and 2,6-lutidine.
Claim 20
Dependent Claim 26 words
The process according to claim 7 wherein the columns packed with the polystyrene, hydrophobic crosslinked divinyl benzene polymer are eluted with phosphate buffer at neutral pH.

References Cited (Backward Citations)

US3950357A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-12-28 1980-06-28 1980-12-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-12-28 1984-06-28 1984-12-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-12-28 1988-06-28 1988-12-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag